Drug-Related Acute Hepatitis
Sanjay Kakar, MD
Key Facts
Etiology/Pathogenesis
-
2 chief mechanisms: Intrinsic and idiosyncratic
-
Idiosyncratic is the most common in children
-
-
Herbal and botanical drugs are important but often overlooked cause of hepatotoxicity
Clinical Issues
-
Classified into hepatitic, cholestatic, or mixed based on pattern of enzyme elevation
-
DILI with autoimmune markers can be indistinguishable from de novo AIH
-
Symptomatic and biochemical improvement in most cases on withdrawal of drug
-
Minority of cases progress to chronic hepatitis and, rarely, cirrhosis
-
Jaundice, high AST levels, and preexisting chronic liver disease are adverse prognostic factors
-
Microscopic Pathology
-
Most medications produce inflammation-predominant pattern
-
Most toxins & a few medications like acetaminophen produce necrosis-predominant pattern
-
Concomitant bile duct injury, eosinophils, granulomas, perivenular necrosis, and cholestasis out of proportion to hepatocellular injury suggest DILI, but none of these is specific
Top Differential Diagnoses
-
Inflammation-predominant pattern: Acute viral hepatitis, autoimmune hepatitis, Wilson disease
-
Necrosis-predominant pattern: Herpes/adenoviral hepatitis, ischemic necrosis, acute venous outflow obstruction
ETIOLOGY/PATHOGENESIS
2 Chief Mechanisms
-
Intrinsic hepatotoxicity
-
Predictable, dose-dependent hepatocellular damage by drug or its metabolite
-
Industrial, household, or environmental toxins
-
-
Typical histological feature is necrosis with negligible inflammation
-
-
Idiosyncratic hepatoxicity
-
Majority of adverse drug reactions fall in this category; antimicrobial and central nervous system drugs are the most common offending agents in children
-
Further classified into metabolic and immunological categories
-
Metabolic: Drug is metabolized into toxic metabolite in predisposed individuals
-
Immunological: “Drug allergy” or hypersensitivity following sensitization to drug
-
-
Typical histological feature is inflammation-predominant liver injury
-
Herbals/Botanicals
-
Important but often overlooked cause of hepatotoxicity
-
Not regulated by Food and Drug Administration and hence not subject to rigorous testing
-
Nearly 20% of American adults have used herbal remedies, and > 5 billion dollars are spent on these annually
-
Contaminants in herbal supplements, including heavy metals such as arsenic, cadmium, lead, or mercury, can also lead to liver toxicity
CLINICAL ISSUES
Presentation
-
Clinical patterns of injury classified based on pattern of liver enzyme abnormalities
-
Hepatitic
-
Acute hepatitis with autoimmune markers may mimic autoimmune hepatitis (AIH)
-
May have features of hypersensitivity like rash, arthralgia, and peripheral eosinophilia
-
Progression to chronic hepatitis with fibrosis and even cirrhosis can occur
-
-
Cholestatic
-
Mixed
-
-
Classified into acute or chronic based on duration of injury
-
Establishing drug as causative agent is key
-
Temporal profile of onset of liver dysfunction is crucial
-
Liver toxicity may manifest weeks or months after drug ingestion and even after drug has been stopped
-
Systematic literature search for each drug that patient has been taking is necessary
-
If observed and reported patterns of clinical and histological injury are similar, case for drug-induced liver injury (DILI) is strengthened
-
Rechallenge can help confirm drug etiology but is rarely done
-
Laboratory Tests
-
Measurement of serum levels of drug or its metabolite can be helpful in diagnosis (e.g., acetaminophen toxicity)
-
Antinuclear &/or anti-smooth muscle antibodies may be present
-
Transaminase elevations may be marked
Treatment
-
Drug withdrawal
-
Steroids may be necessary
Prognosis
-
Symptomatic and biochemical improvement in most cases on withdrawal of drug
-
Liver enzymes can remain elevated for up to several months after discontinuation of drug
-
Minority of cases progress to chronic hepatitis and, rarely, cirrhosis (despite drug withdrawal)
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

